Evidence map›Paper›PMID 42105332›Full record

ArticleAIDS (London, England)2026

Effect of hospitalization on cognitive and physical function in people with HIV.

Lakshmi Chauhan, Kunling Wu, Katherine Tassiopoulos, Leah H Rubin, Todd T Brown, Alison Abraham, Ronnie Kasirye, Susan Koletar, Frank J Palella, Kristine M Erlandson

Abstract read
In one paragraph

Article in AIDS (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lakshmi ChauhanDivision of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Kunling WuCenter for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Katherine TassiopoulosCenter for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Leah H RubinDepartments of Neurology, Psychiatry and Behavioral Sciences, Molecular and Comparative Pathobiology, and Epidemiology.
Todd T BrownDivision of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University, Baltimore, Maryland.
Alison AbrahamDepartment of Epidemiology, Colorado School of Public Health, Aurora, Colorado.
Ronnie KasiryeMakerere University-Johns Hopkins Research Collaboration.
Susan KoletarDivision of Infectious Diseases, The Ohio State University, Columbus, Ohio.
Frank J PalellaDivision of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Kristine M ErlandsonDivision of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)UM1AI068634 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Marlene Ann Cooper, Michael David Hughes · 2011 to 2026
$246.6M
Validation, CLIA and Qualification (VQC): Enhancing the RS ratio as a tool for AIDS Clinical Trial Group (ACTG) tuberculosis trialsUM1AI106701 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$116.8M
UCSD Department of Medicine HIV/AIDS Clinical Trials UnitUM1AI069432 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TIMOTHY J. WILKIN · 2012 to 2026
$50.4M
University of Pittsburgh Clinical Trials UnitUM1AI069494 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SUSAN L KOLETAR, John W Mellors · 2012 to 2026
$38.0M
The Johns Hopkins University - Uganda Clinical Trials UnitUM1AI069530 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MARY Glenn Fowler, Philippa Musoke · 2012 to 2026
$34.8M
Northwestern University Clinical Trial UnitUM1AI069471 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Chad J Achenbach · 2012 to 2026
$24.6M
WOMEN'S HEALTH AGENDAU01AI025868 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ERON, JOSEPH J. · 1987 to 2006
$14.9M
Mentoring Across Disciplines: Aging and Infectious Diseases with a Focus on MobilityK24AG082527 · NIA · UNIVERSITY OF COLORADO DENVER · PI Kristine Mace Erlandson · 2023 to 2026
$768k
NIAID NIH HHS U01 AI025868NIAID NIH HHS UM1 AI068634NIAID NIH HHS UM1 AI068636NIAID NIH HHS UM1 AI069432NIAID NIH HHS UM1 AI069471NIAID NIH HHS UM1 AI069494NIAID NIH HHS UM1 AI069530NIAID NIH HHS UM1 AI106701NIA NIH HHS K24 AG082527
6 · The paper itself

Abstract

backgroundHospitalization contributes to cognitive and physical decline among older adults. We aimed to determine the impact of hospitalization on cognitive and physical function among people with HIV (PWH).

methodsParticipants who had been hospitalized and had cognitive or physical function assessments were included. Cognitive function (a composite of Z -scores for three cognitive tests; NPZ3), gait speed, and grip strength slope differences before and after hospitalization were adjusted for potential confounding variables.

resultsOf 892 participants, 208 had ≥1 hospitalization: 198 had NPZ3 scores and 197 had gait/grip measures. The median age was 58 years, 37% were Black, and 14% Hispanic; median CD4 was 656 cells/mm 3 , 94% had HIV-1 <200 copies/ml. The NPZ-3 slope difference after vs. before hospitalization was -0.071 per year (95% CI = -0.167, 0.026), with significant difference among those admitted for 3-6 days (-0.177 [95% CI -0.336, -0.018]) but not <3 or >6 days. The grip strength slope difference was -0.626 kg per year (95% CI -1.749, 0.497), with significant decline among those admitted for 3-6 days (-1.60 kg per year [95% CI -3.04, -1.52], P  = 0.03) but not <3 or >6 days. The gait speed increase was significant among those admitted for 3-6 days (0.044 m/s [0.005,0.083], P  = 0.03) but not for those with <3 or >6 days.

conclusionsIntermediate duration of hospitalization was associated with modest declines in posthospitalization cognitive function (predominantly psychomotor performance) and grip strength.

Indexed as

CognitionHIV InfectionsHospitalizationPhysical Functional PerformanceAgedFemaleHand StrengthHumansMaleMiddle Agedcognitive functionHIVhospitalizationphysical functionpsychomotor performance

Identifiers

PMID42105332
PMCPMC13264517

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.